Targeted Therapies Offer New Treatment Options for R/R MZL Across Subtypes
SCCA's Stephen Douglas Smith, MD, recently discussed targeted therapies and treatment options for marginal zone lymphomas, a group of B-cell non-Hodgkin lymphomas.
Targeted therapy
A type of treatment that uses drugs or other substances to identify and attack specific types of cancer cells while causing less harm to normal cells.
A type of treatment that uses drugs or other substances to identify and attack specific types of cancer cells while causing less harm to normal cells. Some targeted therapies block the action of certain enzymes, proteins or other molecules involved in the growth and spread of cancer cells. Other types of targeted therapies help the immune system kill cancer cells, or they deliver toxic substances directly to cancer cells and kill them. Targeted therapy may have fewer side effects than other types of cancer treatment. Most targeted therapies are either small molecule drugs or monoclonal antibodies.
